ProCE Banner Activity

Therapy for Previously Treated Advanced HER2-Negative Gastric/GEJ Cancers

Slideset Download
Download these slides from a live webinar reviewing current and emerging therapies for previously treated advanced HER2-negative gastric/GEJ cancers.

Released: July 21, 2022

Expiration: July 20, 2023

No longer available for credit.

Share

Faculty

Samuel Klempner

Samuel Klempner, MD

Associate Professor
Department of Medicine, Division of Hematology-Oncology
Mass General Cancer Center, Harvard Medical Center
Boston, Massachusetts

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by an educational grant

Astellas Pharma US

Faculty Disclosure

Primary Author

Samuel Klempner, MD

Associate Professor
Department of Medicine, Division of Hematology-Oncology
Mass General Cancer Center, Harvard Medical Center
Boston, Massachusetts

Samuel Klempner, MD: consultant/advisor/speaker: Astellas, AstraZeneca, Bristol-Myers Squibb, Daiichi-Sankyo, Exact Sciences, Lilly, Merck, Mersana, Sanofi-Aventis.